Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
ESC Congress 2013 media alert
The world's greatest event in cardiology, ESC Congress 2013, will take place in Amsterdam, the Netherlands, from 31 August to 4 September, and as ever promises journalists a rich source of front-page news and feature background.The spotlight of this year's event is “The Heart Interacting with Systemic Organs”, reflecting an interaction which, says Professor Keith Fox, Chairman of the Congress Programme Committee, will encourage critical discussion of new research and techniques with other organ experts and their transfer into clinical medicine.
ESC Congress 2013 will take place at theAmsterdam RAI congress centreEuropaplein, Amsterdamfrom 31 August to 4 SeptemberJournalists planning to attend are invited to registervia the congress press section of the ESC website
ESC Congress 2013 in Amsterdam is expected to attract more than 30,000 registered participants (as well as 750 registered press), making it the world’s premier conference on the science, management and prevention of cardiovascular disease, and a guaranteed source of important news stories. In cardiology, says Professor Fox, the ESC Congress has indisputably become the number one international event, reflected in the high number of submissions from non-European countries and in participant registrations.This year's congress will feature:
Press support in Amsterdam will be concentrated on three press conferences per day (from Sunday to Tuesday), which are led each morning by the late-breaking results of clinical trials selected for Hot Line sessions. These are studies (many of which are reported simultaneously and under embargo in the leading medical journals) whose outcomes will shape the treatment of cardiovascular disease in the years to come, and which traditionally provide front-page news across the world. This year, four Hot Line sessions will feature results from 20 major trials in thrombosis, coronary intervention and devices, diabetes, and heart failure and acute coronary syndromes.Included among them are results from the Hokusai VTE study, the largest single-agent phase III trial for the treatment and prevention of recurrent venous thromboembolism. Also presented will be results from the phase III EXAMINE (EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome) trial, a cardiovascular safety study of alogliptin in patients with type 2 diabetes and acute coronary syndrome. Results will also be presented from the ATOMIC-AHF (Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure), a phase IIb clinical trial of an intravenous formulation of omecamtiv mecarbil. Of interest too in its centenary year will be a Tour de France study - an analysis of mortality data from post-1947 participants whose deaths have since been reported.The press conference programme will also feature new developments derived from other studies submitted as abstracts and collected under eight themed headings:
Press releases in support of the press conferences will be issued under embargo a few days in advance. Accredited journalists can also make use of a well serviced press room, with wi-fi and work space available.In the meantime, we encourage you to mark the dates in your diary, and to contact the ESC Press Office for further information.* ESC Congress 2013 will take place from 31 August to 4 September at the RAI Congress Center, Europaplein, Amsterdam, the Netherlands* Information on the scientific programme is already available online* More information on ESC Congress 2013 (including details for press registration and accommodation) is available here and from the ESC's press office at firstname.lastname@example.org.
About ESC Congress 2013 The ESC Congress is currently the world’s premier conference on the science, management and prevention of cardiovascular disease.
About press registration and facilities- Free press registration is conducted online via "My ESC" supported by presentation of a press card or letter of assignment with proof of three published articles together with the filled in and signed embargo form. - Online registration is now open, click here.
- On-site registration opens 30 August 2012 in Amsterdam.
- A hotel has been exclusively reserved for the press. After registering for the congress, please contact the ESC Press Office for a password to give to the agent organising hotel bookings.
- The ESC provides a fully equipped Press Centre at the ESC Congress 2013. This includes the official ESC Press Conference Room, exclusive Press Working Area, catering, interview rooms and Press Offices.
About the ESC The European Society of Cardiology (ESC) represents more than 80,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
© 2017 European Society of Cardiology. All rights reserved